Skip to main content
Clinical Trials/ITMCTR1900002645
ITMCTR1900002645
Not yet recruiting
Phase 1

An optimized clinical treatment strategy and its mechanisms for Shen-Qi Sequential Therapy in the prevention and treatment of Diabetic Macrovascular Diseases based on the TCM theory of Latent Pathogen

Hospital of Chengdu University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Diabetic Lower Extremity Artery Disease
Sponsor
Hospital of Chengdu University of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Hospital of Chengdu University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • To be included in the study, patients must have:
  • (1\) Diagnosis of LEAD of diabetes as well as Qi\-yin deficiency with blood stasis syndrome according to WM and TCM;
  • (2\) According to Fontaine stage of LEAD, patients with stage I, IIa and IIb are eligible;
  • (3\) Aged between 35 and 75 years;
  • (4\) HbA1c \<\= 9\.0%;
  • (5\) Women of childbearing age are required negative pregnancy test and agree to use reliable contraception measures during the study;
  • (6\) Voluntarily participate in the test and sign the informed consent;

Exclusion Criteria

  • Patients will be excluded from the study if they meet any of the following criteria:
  • (1\) Patients with cardiac and renal insufficiency, acute coronary syndrome, cerebrovascular accident, vasculitis, venous dysfunction of lower limbs, hematopoietic system disorders and mental diseases;
  • (2\) Patients with acute metabolic disorders such as diabetic ketoacidosis within the past 1 month;
  • (3\) Severe infection in the past 1 month;
  • (4\) Patients with allergic constitution;
  • (5\) Uncooperative in run\-in period;
  • (6\) Having a history of alcoholism or drug abuse;
  • (7\) A history of another clinical study in the previous 3 months;
  • (8\) Patients considered by the investigator to be unfit for this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials